INGN logo

Inogen (INGN) EBITDA

Annual EBITDA

-$58.34 M
-$48.77 M-509.74%

December 31, 2023

Summary

Performance

1-Year Change

-509.74%

3-Year Change

-989.87%

5-Year Change

-218.61%

15-Year Change

-246.24%

INGN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.42%
INGN annual EBITDA is higher than 29.42% of companies in Healthcare sector

High & Low

All-time High

$49.19 M
INGN annual EBITDA is currently -218.61% below its historical high of $49.19 million

3-Year Low

-$58.34 M
INGN annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
INGN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 25, 2025
INGN next annual earnings announcement is scheduled for Feb 25, 2025

OtherINGNprofitabilitymetrics:

Annual Revenue

$315.66 M
INGN annual revenue is $315.66 million

Annual Net Income

-$102.45 M
INGN annual net profit is -$102.45 million

Annual EBIT

-$76.49 M
INGN annual earnings before interest & taxes is -$76.49 million

Annual EPS

-$4.42
INGN annual earnings per share is -$4.42

Quarterly EBITDA

-$2.48 M
-$759.00 K-44.15%

September 30, 2024

Summary

Performance

3-Month Change

-44.15%

1-Year Change

+73.1%

3-Year Change

+73.1%

5-Year Change

+73.1%

INGN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

60.67%
INGN quarterly EBITDA is higher than 60.67% of companies in Healthcare sector

High & Low

All-time High

$16.91 M
INGN quarterly EBITDA is currently -114.65% below its historical high of $16.91 million

3-Year Low

-$23.84 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 25, 2025
INGN next earnings announcement is scheduled for Feb 25, 2025

OtherINGNprofitabilitymetrics:

Quarterly Revenue

$88.83 M
INGN quarterly revenue is $88.83 million

Quarterly Net Income

-$5.96 M
INGN quarterly net profit is -$5.96 million

Quarterly EBIT

-$7.79 M
INGN quarterly earnings before interest & taxes is -$7.79 million

Quarterly EPS

-$0.25
INGN quarterly earnings per share is -$0.25

TTM EBITDA

-$39.04 M
+$6.74 M+14.71%

September 30, 2024

Summary

Performance

3-Month Change

+14.71%

1-Year Change

-12.03%

3-Year Change

-12.03%

5-Year Change

-12.03%

INGN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.83%
INGN TTM EBITDA is higher than 36.83% of companies in Healthcare sector

High & Low

All-time High

$49.87 M
INGN TTM EBITDA is currently -178.29% below its historical high of $49.87 million

3-Year Low

-$58.34 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 25, 2025
INGN next earnings announcement is scheduled for Feb 25, 2025

OtherINGNprofitabilitymetrics:

TTM Revenue

$331.52 M
INGN TTM revenue is $331.52 million

TTM Net Income

-$52.69 M
INGN TTM net profit is -$52.69 million

TTM EBIT

-$60.11 M
INGN TTM earnings before interest & taxes is -$60.11 million

TTM EPS

-$2.25
INGN TTM earnings per share is -$2.25

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$58.34 M
INGN annual EBITDA is -$58.34 million

Annual Net Income

-$102.45 M
INGN annual net profit is -$102.45 million

Annual Interest Expense

-
INGN annual interest expense value is unknown

Annual Income Tax

$105.00 K
INGN annual income tax is $105.00 thousand

Annual D&A

$18.15 M
INGN annual depreciation & amortization is $18.15 million

INGN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-509.7%+73.1%-12.0%
3 y3 years-989.9%+73.1%-12.0%
5 y5 years-218.6%+73.1%-12.0%

INGN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-289.0%at low-183.4%+89.6%-226.5%+33.1%
5 y5-year-273.5%at low-114.7%+89.6%-216.1%+33.1%
alltimeall time-218.6%at low-114.7%+89.6%-178.3%+33.1%

Inogen EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.48 M(+44.2%)
-$39.04 M(-14.7%)
Jun 2024
-
-$1.72 M(-84.4%)
-$45.78 M(-11.1%)
Mar 2024
-
-$11.01 M(-53.8%)
-$51.52 M(-11.7%)
Dec 2023
-$58.34 M(+509.7%)
-$23.84 M(+158.7%)
-$58.34 M(+67.4%)
Sep 2023
-
-$9.21 M(+23.5%)
-$34.85 M(+16.2%)
Jun 2023
-
-$7.46 M(-58.2%)
-$30.00 M(+53.3%)
Mar 2023
-
-$17.83 M(+4994.0%)
-$19.57 M(+104.5%)
Dec 2022
-$9.57 M(-131.0%)
-$350.00 K(-92.0%)
-$9.57 M(-5.5%)
Sep 2022
-
-$4.36 M(-246.8%)
-$10.12 M(-265.0%)
Jun 2022
-
$2.97 M(-138.0%)
$6.14 M(-69.4%)
Mar 2022
-
-$7.83 M(+763.8%)
$20.08 M(-35.0%)
Dec 2021
$30.87 M(+370.8%)
-$906.00 K(-107.6%)
$30.87 M(-1.0%)
Sep 2021
-
$11.90 M(-29.7%)
$31.18 M(+41.6%)
Jun 2021
-
$16.91 M(+470.2%)
$22.02 M(+204.2%)
Mar 2021
-
$2.97 M(-598.5%)
$7.24 M(+10.4%)
Dec 2020
$6.56 M(-80.5%)
-$595.00 K(-121.7%)
$6.56 M(+1.7%)
Sep 2020
-
$2.74 M(+28.7%)
$6.45 M(-58.3%)
Jun 2020
-
$2.13 M(-6.7%)
$15.48 M(-45.2%)
Mar 2020
-
$2.28 M(-424.8%)
$28.25 M(-16.0%)
Dec 2019
$33.62 M(-31.6%)
-$703.00 K(-106.0%)
$33.62 M(-19.7%)
Sep 2019
-
$11.77 M(-21.0%)
$41.88 M(-3.1%)
Jun 2019
-
$14.90 M(+94.8%)
$43.21 M(-4.3%)
Mar 2019
-
$7.65 M(+1.4%)
$45.15 M(-8.2%)
Dec 2018
$49.19 M
$7.55 M(-42.4%)
$49.19 M(-1.4%)
DateAnnualQuarterlyTTM
Sep 2018
-
$13.11 M(-22.1%)
$49.87 M(+3.8%)
Jun 2018
-
$16.84 M(+44.0%)
$48.03 M(+12.2%)
Mar 2018
-
$11.69 M(+42.0%)
$42.81 M(+7.3%)
Dec 2017
$39.89 M(+9.9%)
$8.23 M(-26.9%)
$39.89 M(-2.1%)
Sep 2017
-
$11.27 M(-3.0%)
$40.76 M(+6.3%)
Jun 2017
-
$11.61 M(+32.4%)
$38.36 M(+0.4%)
Mar 2017
-
$8.78 M(-3.6%)
$38.21 M(+5.3%)
Dec 2016
$36.29 M(+26.2%)
$9.10 M(+2.7%)
$36.29 M(+6.6%)
Sep 2016
-
$8.87 M(-22.7%)
$34.05 M(+5.0%)
Jun 2016
-
$11.47 M(+67.4%)
$32.43 M(+9.0%)
Mar 2016
-
$6.85 M(-0.2%)
$29.74 M(+3.4%)
Dec 2015
$28.76 M(+27.4%)
$6.87 M(-5.2%)
$28.76 M(+8.4%)
Sep 2015
-
$7.24 M(-17.5%)
$26.54 M(+1.8%)
Jun 2015
-
$8.78 M(+49.7%)
$26.07 M(+7.8%)
Mar 2015
-
$5.87 M(+26.3%)
$24.19 M(+7.1%)
Dec 2014
$22.58 M(+74.3%)
$4.65 M(-31.4%)
$22.58 M(+7.7%)
Sep 2014
-
$6.77 M(-2.0%)
$20.97 M(+20.0%)
Jun 2014
-
$6.91 M(+62.3%)
$17.47 M(+19.0%)
Mar 2014
-
$4.26 M(+40.4%)
$14.68 M(+13.4%)
Dec 2013
$12.95 M(+113.8%)
$3.03 M(-7.3%)
$12.95 M(+11.0%)
Sep 2013
-
$3.27 M(-20.7%)
$11.67 M(+38.9%)
Jun 2013
-
$4.12 M(+63.3%)
$8.40 M(+96.4%)
Mar 2013
-
$2.53 M(+44.3%)
$4.28 M(+144.3%)
Dec 2012
$6.06 M(+312.2%)
$1.75 M
$1.75 M
Dec 2011
$1.47 M
-
-

FAQ

  • What is Inogen annual EBITDA?
  • What is the all time high annual EBITDA for Inogen?
  • What is Inogen annual EBITDA year-on-year change?
  • What is Inogen quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Inogen?
  • What is Inogen quarterly EBITDA year-on-year change?
  • What is Inogen TTM EBITDA?
  • What is the all time high TTM EBITDA for Inogen?
  • What is Inogen TTM EBITDA year-on-year change?

What is Inogen annual EBITDA?

The current annual EBITDA of INGN is -$58.34 M

What is the all time high annual EBITDA for Inogen?

Inogen all-time high annual EBITDA is $49.19 M

What is Inogen annual EBITDA year-on-year change?

Over the past year, INGN annual EBITDA has changed by -$48.77 M (-509.74%)

What is Inogen quarterly EBITDA?

The current quarterly EBITDA of INGN is -$2.48 M

What is the all time high quarterly EBITDA for Inogen?

Inogen all-time high quarterly EBITDA is $16.91 M

What is Inogen quarterly EBITDA year-on-year change?

Over the past year, INGN quarterly EBITDA has changed by +$6.74 M (+73.10%)

What is Inogen TTM EBITDA?

The current TTM EBITDA of INGN is -$39.04 M

What is the all time high TTM EBITDA for Inogen?

Inogen all-time high TTM EBITDA is $49.87 M

What is Inogen TTM EBITDA year-on-year change?

Over the past year, INGN TTM EBITDA has changed by -$4.19 M (-12.03%)